穿透性角膜移植术后继发性青光眼的临床分析  

Secondary glaucoma after penetrating keratoplasty

作　　者：谢立信[1] 史伟云[1] 刘敬[1] 李绍伟[1] 曹景[1] 

机构地区：[1]山东省医学科学院眼科研究所,青岛266071

出　　处：《中华眼科杂志》2000年第2期116-118,共3页Chinese Journal of Ophthalmology

摘　　要：目的　探讨穿透性角膜移植术后继发性青光眼的病因及相应处理措施。方法　对145 0例 ( 15 0 0只眼 )穿透性角膜移植术后患者的资料进行回顾性分析 ,探讨其中 80例 ( 80只眼 )继发性青光眼的发生原因、时间及与原发病的关系 ,并根据不同发生原因的继发性青光眼分别行药物或手术治疗。结果　 6 3只眼经药物治疗后 2或 3周眼压恢复正常。 17只眼行抗青光眼手术 ,其中 13只眼的眼压得到控制 ,4只眼眼压仍高。结论　穿透性角膜移植围手术期的正确处理能够降低继发性青光眼的发生率。根据继发性青光眼的不同病因进行相应治疗 。Objective To investigate the etiology and management of secondary glaucoma after penetrating keratoplasty (PKP) Methods Eighty cases (80 eyes) with secondary glaucoma occurring in 1 450 cases (1 500 eyes) of PKP, its causes, time of onset and the relationship with the primary disease were analyzed According to different causes, they were treated with different therapies Results The intraocular pressure (IOP) of 63 cases (63 eyes) became normal after drug treatment for 23 weeks In 17 cases (17 eyes) who had received antiglaucomatous operations, 13 cases′ (13 eyes) IOPs were normal and 4 cases′ (4 eyes) still high Conclusions Accurate perioperative management can decrease the incidence of secondary glaucoma after PKP The majority of secondary glaucoma can be controlled by different therapies according to different causes

关 键 词：青光眼 穿透性角膜移植 继发性 

分 类 号：R779.65[医药卫生—眼科]